Clinical trial
Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or…
NCT00112866 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00112866 |
|---|---|
| Title | Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme |
| Official title | Phase II Trial of EMD 121974 for Recurrent Glioblastoma: A Clinical Trial With Tissue Correlates of Response |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor |
| Intervention type | Drug, Other, Procedure |
| Interventions | cilengitide, therapeutic conventional surgery, pharmacological study, laboratory biomarker analysis |
| Enrollment | 30 |
| Start date | Jan 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Mar 1, 2009 |
| First posted | Jun 3, 2005 |
| Last update posted | Jun 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: